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Obesity-induced kidney injury 
is attenuated by amelioration 
of aberrant PHD2 activation in 
proximal tubules
Koji Futatsugi1, Hirobumi Tokuyama1, Shinsuke Shibata2, Makiko Naitoh1, Takeshi Kanda1, 
Hitoshi Minakuchi1, Shintaro Yamaguchi1, Koichi Hayashi1, Yoji Andrew Minamishima3, 
Motoko Yanagita4, Shu Wakino1 & Hiroshi Itoh1
The involvement of tissue ischemia in obesity-induced kidney injury remains to be elucidated. 
Compared with low fat diet (LFD)-mice, high fat diet (HFD)-fed mice became obese with tubular 
enlargement, glomerulomegaly and peritubular capillary rarefaction, and exhibited both tubular and 
glomerular damages. In HFD-fed mice, despite the increase in renal pimonidazole-positive areas, the 
expressions of the hypoxia-responsive genes such as Prolyl-hydroxylase PHD2, a dominant oxygen 
sensor, and VEGFA were unchanged indicating impaired hypoxic response. Tamoxifen inducible 
proximal tubules (PT)-specific Phd2 knockout (Phd2-cKO) mice and their littermate control mice 
(Control) were created and fed HFD or LFD. Control mice on HFD (Control HFD) exhibited renal damages 
and renal ischemia with impaired hypoxic response compared with those on LFD. After tamoxifen 
treatment, HFD-fed knockout mice (Phd2-cKO HFD) had increased peritubular capillaries and the 
increased expressions of hypoxia responsive genes compared to Control HFD mice. Phd2-cKO HFD 
also exhibited the mitigation of tubular damages, albuminuria and glomerulomegaly. In human PT 
cells, the increased expressions of hypoxia-inducible genes in hypoxic condition were attenuated by 
free fatty acids. Thus, aberrant hypoxic responses due to dysfunction of PHD2 caused both glomerular 
and tubular damages in HFD-induced obese mice. Phd2-inactivation provides a novel strategy against 
obesity-induced kidney injury.
Obesity is worldwide health problem with a variety of complications including hypertension, dyslipidemia, 
and abnormal glucose metabolism. Obesity is also considered as a major risk factor for chronic kidney disease 
(CKD)1. Renal structural and functional changes develop early during obesity whose lesions might affect those 
observed in the early phase of diabetic nephropathy, a leading cause of end-stage renal disease2,3. Previous studies 
of renal histological changes in obesity focused primarily on the glomerular area4. Obesity-related glomerulopa-
thy has been well defined, characterized by glomerulomegaly with or without focal segmental glomerulosclerosis4. 
We recently reported that excess in fat intake causes obesity and renal injury in C57BL/6J mice, with not only 
enlarged glomeruli, but also enlarged and vacuolated tubules, particularly proximal tubules (PT)5. Other investi-
gators also reported histological changes in the renal tubules in obesity and diabetes6,7.
Although previous studies reported that diabetes induced a hypoxic condition in the kidney, it has not been 
determined whether this condition is also evident in obesity8,9. PT cells are easily damaged by hypoxia because 
their volume accounts for more than 80% of the kidney cortex, to which oxygen is supplied only by the peritu-
bular capillaries10. PT cells consume oxygen constantly, utilizing it for energy production to drive reabsorption 
and excretion of various substances. Accordingly, hypoxia, as a pathologic imbalance between oxygen supply and 
consumption, affects the PT areas. Therefore, hypertrophic PT cells in obese subjects might be readily susceptible 
to an inefficient oxygen supply, resulting in a hypoxic condition.
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When there is an imbalance between oxygen demand and supply, cells activate hypoxic responses to protect 
themselves against the hypoxic environment. Among the molecules responsible for tissue hypoxic response, 
the transcription factor hypoxia-inducible factor (HIF), which is composed of HIF-1, HIF-2 and HIF-3, is 
the master regulator of the hypoxic responses. Although little is known about the cell type-specific functions 
of HIFs in response to ischemic kidney injury, many cellular adaptive processes are regulated by HIF-111,12. 
Experiments on cells bearing inactivating mutations in the HIF pathway have emphasized the importance 
of HIF-1 on the regulation of genes involved in angiogenesis13. HIF-1 consists of α -subunit (HIF-1α ) and 
β -subunit (HIF1-β /ARNT), and HIF-1α proteins are targeted for protein degradation by prolyl-hydroxylases 
(PHDs)14. PHDs function as tissue oxygen sensor molecules by regulating the stability of HIFα proteins in an 
oxygen-dependent manner. In normal oxygen availability, prolyl hydroxylation of HIFα by PHDs enables its 
association with the von Hippel-Lindau tumor suppressor E3 ubiquitin ligase complex, leading to the degrada-
tion of HIFα via the ubiquitin-proteasome pathway15. In hypoxia, the activities of PHDs are inhibited, result-
ing in stabilized HIFα , which dimerizes with HIFβ , and activates the transcription of HIF-target genes such 
as glucose transporter 1 (GLUT1), phosphoglycerate kinase 1 (PGK1), and lactate dehydrogenase A (LDHA). 
PHDs comprise three isoforms, PHD1, PHD2 and PHD312,15. Previous studies reported that among the three 
isoforms, PHD2, not PHD1 and PHD3, is a major negative regulator for vascular growth in adult mice15. When 
PHD2 is inactivated by hypoxia, accumulation of HIF-1α leads to the induction of vascular endothelial growth 
factor (VEGF) which enhances the growth of vascular beds. Considering that PT cells are enlarged in obesity 
and are easily damaged by hypoxia, we hypothesized that cellular adaptive processes are crucial for the patho-
physiology of obesity-induced renal injury.
In this study, we used high-fat-diet (HFD)-fed C57BL/6J background mice as an obese mice model. Though 
this model is characterized by increased plasma free fatty acids (FFA) and insulin levels with impaired glucose 
tolerance, they did not show frank hyperglycemia. This model is relevant to study obesity-related nephropathy3. 
We observed renal hypoxia with perivascular rarefaction and PT enlargement in HFD-induced obese mice. 
Even though kidney tissue became hypoxic in HFD model, as shown by pimonidazole positive staining, hypoxic 
responses in HFD model appeared dysfunctional. Some of the HIF-1α target mRNAs including Vegfa, Slc2a1, 
Pgk1, and Ldha were not upregulated in response to hypoxia, indicating a lack of HIF-1α activation. By using 
tamoxifen (Tam)-inducible PT-specific Phd2 knockout mice, we demonstrated that deletion of Phd2 in PT cells 
mitigated the renal damage, by ameliorating the peritubular capillary rarefaction and tissue ischemia. Our data 
suggest that the inhibition of PHD2 in PT cells is a potential therapeutic strategy against obesity-induced kidney 
disease.
Results
Renal morphological changes and the hypoxic state in HFD-fed mice. In mice fed HFD, body 
weight increased but blood pressure did not change (Table 1). Though fasting blood glucose did not differ 
between the two groups, serum levels of triglycerides, FFA, and insulin in fasted mice were higher in HFD-fed 
mice (Table 1). HFD-induced obese mice exhibited renal damage as indicated by albuminuria and excretion of 
the proximal tubular injury markers, neutrophil gelatinase-associated lipocalin (NGAL) and cystatin C (Fig. 1A) 
though serum creatinine levels were not changed (Table 1). These biochemical data were consistent with renal 
damage in obesity5. In histology, kidneys from HFD-fed mice exhibited marked mesangial hypercellularity and 
enlarged glomerular size. In addition, PT cellular size was increased in mice fed HFD, compared with in those fed 
LFD (Fig. 1B). These hypertrophic changes suggested a spatial sparse of peritubular capillary (PTC) beds. CD34-
positive cell counts revealed that PTC density in the kidney was significantly decreased in HFD compared with 
LFD-fed mice (Fig. 1C). Because of PT enlargement and PTC rarefaction, we hypothesized that HFD-fed mice 
had PT hypoxia and performed pimonidazole staining to examine this alteration. Compared with LFD-fed mice, 
HFD-fed mice showed significantly increased pimonidazole-positive areas (Fig. 1D).
Hypoxic response in kidneys of HFD-fed mice. To confirm molecular changes responsive to hypoxia, 
expressions of the downstream hypoxia-responsive molecules, including PHD2 and VEGF, were measured. 
Though the pimonidazole-positive areas in HFD-fed mice were significantly larger than in LFD-fed mice, expres-
sions of either PHD2 (Fig. 2A) or genes downstream to PHD, including, Vegfa (VEGF-A), Pgk1 (PGK1), Slc2a1 
(Glut-1), and Ldha (LDHA) (Fig. 2B) were not different between mice fed two diets. These data indicated that, in 
obese mice, renal tissues showed abnormal hypoxic responses.
LFD-fed mice HFD-fed mice
Body Weight (g) 32.9 ± 0.811 40.4 ± 1.499**
Systolic blood pressure (mmHg) 111 ± 2.07 116 ± 2.19
Diastolic blood pressure (mmHg) 64.9 ± 1.83 66.8 ± 1.11
Total cholesterol (mg/dl) 74.8 ± 2.35 214 ± 11.9**
Free tatty acid (mEq/l) 0.395 ± 0.0941 1.06 ± 0.132*
Fasting blood glucose (mg/dl) 116 ± 26 126 ± 22
Fasting insulin (ng/ml) 4.39 ± 1.82 10.3 ± 1.84*
Serum Creatinine (mg/dl) 0.797 ± 0.204 0.967 ± 0.322
Table 1.  The baseline characteristics of LFD-fed or HFD-fed mice. Data were presented with mean ± SEM, 
**p < 0.01 vs. LFD-fed mice, *p < 0.05 vs. LFD-fed mice, n = 8.
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Generation of tamoxifen-inducible PT-specific PHD2 knockout mice. To explore the role of an 
impaired hypoxic response in obese mice, we created Tam-inducible PT-specific Phd2 knockout mice (Phd2-cKO) 
by crossing Phd2-floxed  mice (Phd2F/F)16 with knock-in mice harboring Tam-inducible Cre-recombinase gene 
driven by a PT-specific N-myc downstream regulated gene 1 (Ndrg1) promoter17 (Fig. 3A). With Tam treatment, 
PHD2 expression was significantly decreased in the proximal tubules of Phd2-cKO mice on either diet group, 
confirming that Phd2-inactivation by the Cre-loxP system was effective in Phd2-cKO mice (Fig. 3B, columns 4 
and 8). Tam treatment had no effect on PHD2 expression in Control mice (Fig. 3B, comparing columns 1 and 3 
and columns 5 and 7). Immunostaining revealed that PHD2 expression was markedly decreased in Tam-treated 
Phd2-cKO mice (Fig. 3C). Expressions of downstream genes, Vegfa (VEGF-A), Pgk1 (PGK1), Slc2a1 (Glut-1), and 
Ldha (LDHA), were increased in Phd2-cKO mice, suggesting that hypoxia responsible gene downstream of PHD2 
was subsequently induced by inactivating PHD2 (Fig. 3D). Immunostaining also showed the increase in VEGF-A 
Figure 1. Renal injury and histological changes in obese mice. (A) Urinary excretion of albumin (u-Alb, 
left panel), neutrophil gelatinase-associated lipocalin (u-NGAL, middle panel) and cystatin C (right panel).  
(B) Representative pathology of kidneys of mice fed high fat diet (HFD) and low fat diet (LFD). Scale  
bar is 50 μm. Average areas of proximal tubule (PT) cells and glomeruli are shown in the right panel.  
(C) Immunostaining for CD34 (upper panel) in a low power field (LPF, upper pictures) and a high power field 
that focused on CD34+ cells (HPF, lower pictures). Lower bar graph shows the counts of CD34-positive cells 
reflecting the density of peritubular capillaries. Scale bar is 50 μ m. (D) Immunostaining for pimonidazole 
(upper panel) and measurement of pimonidazole-positive areas, indicating a hypoxic state (lower panel). Scale 
bar is 50 μm. *p < 0.05 vs. LFD-fed mice, n = 8.
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Figure 2. Lack of a hypoxic response in kidneys of HFD-fed mice. (A) mRNA expression of PHD2 in high 
fat diet (HFD) and low fat diet (LFD) fed mice. Bar graph represents the quantification of immunostained areas. 
Scale bar indicates 50 μ m. (B) mRNA expression of Vegfa, Slc2a1, Pgk1, and Ldha in HFD and LFD-fed mice. 
Bar graph represents the quantification of immunostained areas. Scale bar is 50 μ m.
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Figure 3. Tamoxifen-inducible proximal tubule-specific PHD2 knockout mice. (A) Representative results 
of genotyping of Phd2 allele (upper panel) and Ndrg1-Cre (lower panel) mice. PCR products are indicated by 
arrows. (B) Real-time RT-PCR analysis of mRNA expression of Phd2 in kidney samples from each experimental 
group. Groups 1–4 represent low fat diet (LFD) and groups 5–8 represent high fat diet (HFD)-fed mice. Groups 
2, 4, 6 and 8 represent mice harboring both Phd2F/F and Ndrg1-Cre genes. Groups 3, 4, 7 and 8 represent mice 
treated with tamoxifen (Tam). *p < 0.05 vs. group 1, #p < 0.05 vs. group 5. (C) Representative immunostaining 
for PHD2 (left panel) and quantitation of immunostained areas (right panel) in Control or Phd2-cKO mice 
fed with LFD or HFD. (D) mRNA expression of Vegfa, Slc2a1, Pgk1, and Ldha in Control or Phd2-cKO mice 
fed with LFD or HFD. (E) Representative immunostaining for VEGF-A (left panel) and quantitation of 
immunostained areas (right panel). *p < 0.05 vs. Control LFD, #p < 0.05 vs. Control HFD. Scale bar indicates 
50 μ m.
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expression in PT of Phd2-cKO mice (Fig. 3E). These data indicated that the hypoxic responses are functionally 
activated in Phd2-cKO mice on HFD as in those on LFD.
Amelioration of the hypoxic condition by restoration of PTC in Tam-inducible PT-specific 
Phd2-cKO mice. Because it is hypothesized that hypoxic response does not work properly, thereby con-
tributing to development of renal pathological lesions in obese mice, we examined effects of PHD2-suppression 
on renal damage using the Tam-inducible PT-specific Phd2-cKO mice. HFD increased body weights of both 
Control and Phd2-cKO mice, with no weight difference between Phd2-cKO and Control mice on either diet group 
(Fig. 4A). HFD increased serum FFA similarly in Phd2-cKO and Control mice (Fig. 4B). Albuminuria, the marker 
for glomerular damages, as well as the markers for proximal tubular injury including urinary excretion of NGAL 
and cystatin C were higher in Control HFD mice compared with Control LFD mice. These HFD-dependent 
changes were attenuated in Phd2-cKO mice with Tam treatment (Fig. 4C). To explore the mechanism whereby 
Phd2 gene silencing ameliorated renal damages in HFD-induced obese mice, we examined the tissue ischemic 
state. The number of CD34-positive cells was decreased in Control HFD mice compared with Control LFD mice. 
This capillary loss was restored in Phd2-cKO HFD mice with Tam treatment (Fig. 4D). Consistent with these 
results, the pimonidazole-positive area was increased in Control HFD mice. However, in Phd2-cKO HFD mice, 
pimonidazole-positive area was smaller, nearly the same as in Control LFD mice (Fig. 4E). In addition to these 
results, electron microscope showed PTC injuries in Control HFD mice. In HFD mice, endothelial cells of PTC 
was enlarged, basement membrane was thickening, slit structures collapsed, and lumen of PTC was narrowing, 
which were ameliorated in Phd2-cKO HFD mice (Fig. 4F). This indicated that, in Phd2-cKO mice, ischemia was 
ameliorated in the HFD-induced obese state. The histological abnormalities in Control HFD mice, including 
glomerulomegaly and enlarged PT cellular size, were completely prevented in Phd2-cKO HFD mice with Tam 
treatment, suggesting that the early intervention could suppress the progression to the renal pathological changes 
of both tubular and glomerular lesions in the HFD-induced obese state (Fig. 4G).
Dysregulation of hypoxic response induced by FFA. To further examine the mechanism for the 
impaired hypoxic response observed in HFD-fed obese mice, a human PT cell line, HK-2 cells, were cultured in 
either normoxic or hypoxic (1% O2) condition to mimic kidney environment in HFD-induced obese mice. The 
expressions of hypoxia-responsible genes downstream of PHD2-HIF pathway including glucose transporter 1 
(GLUT1) and VEGFA were increased under hypoxia (Fig. 5A,B, lanes 1 and 2). We examined the effects of insulin 
or FFA, both of which were systemically elevated in HFD-induced obesity (Table 1). Insulin did not affect the 
expression of SLC2A1 (GLUT1. Fig. 5A, lanes 3 and 4) or VEGFA (Fig. 5B, lanes 3 and 4). However, FFA damp-
ened the upregulation of these genes by hypoxia (Fig. 5A,B, lanes 5 and 6).
Discussion
Obesity and metabolic syndrome are complicated with renal damages in which multiple factors, including 
systemic hypertension, dyslipidemia and abnormal glucose metabolism are involved. We previously reported 
obesity-induced histological changes in the kidney, including glomerular hypercellularity, macrophage infiltra-
tion and vacuolization in PT5. In the present study, we demonstrated that hypoxic tissue insults are present in 
obese kidney, which is caused by PTC rarefaction through the impaired hypoxic response. We also demonstrated 
that the restoration of oxygen supply by induced PT-specific PHD2 deletion mitigated not only in tubular dam-
ages but also glomerular damages. This restoration also ameliorated renal histological changes including both 
tubular and glomerular hypertrophy. Our data provide the evidence for a crucial role of an improper hypoxic 
response in PT to hypoxia in the development of renal lesions of both tubules and glomeruli in the obese condi-
tion. It is also demonstrated how the aberrant PT function propagate to interstitial vascular disorganization or 
glomerular damages to establish the obesity-induced renal damages.
In response to hypoxic stress, cellular adaptive processes are regulated by HIF-1 and HIF-2 in various tissues 
including kidney18. Under hypoxia, PHD2 is inactivated since its activity is dependent on oxygen molecules, and 
the hydroxylation of HIF-1α is inhibited, causing HIF-1α to accumulate and inducing genes downstream to HIF, 
including Vegfa, Pgk1, Slc2a1, and Ldha. However, in the obese mice, even under hypoxic conditions, the expres-
sion of these hypoxia-responsible genes were not induced (Fig. 2), suggesting the impaired hypoxic response. 
Using an inducible gene-engineered mouse model, we have now shown that these lesions were almost fully elim-
inated by PHD2 downregulation in PT, suggesting that obesity-induced renal damage is attributed mainly to the 
lack of an inactivation of PHD2 in PT. This reactivation of HIF-VEGF pathway by deletion of the Phd2 gene in 
PT increased number of PTCs and subsequently prevented hypoxic renal injuries. It was recently reported that 
tubulo-vascular crosstalk involving VEGF is essential to maintain PTC networks in the kidney19,20. Our results 
support this concept, providing new evidence for intercellular communication between PT cells and PTC cells 
and for the pathological relevance of this communication in obesity-induced kidney disease. Moreover, we fur-
ther implicated FFA as one of the candidate factors for impairing the hypoxic response of PT cells although the 
detailed mechanism has not been elucidated. It was demonstrated that the activation of nuclear receptor, peroxi-
some proliferator-activated receptors γ (PPARγ ) induces PHD up-regulation in adipocytes21. Since certain kinds 
of FFA and their derivatives including palmitate and oleate that were used in the present in vitro study have been 
shown to activate PPARγ 22,23. HFD-induced increase in serum FFA concentration might maintain the PHD2 
activity and inhibit the inactivation of PHD2 in spite of hypoxic condition. Our data provide mechanistic clues 
that dyslipidemia is closely associated with CKD progression24,25 and controlling hyperlipidemia could augment 
HIF-VEGF signaling and correct an impaired hypoxic response.
The cellular enlargement of PT, described as histological findings in obesity4,5, would be expected to con-
tribute to the tissue hypoxic condition through the rarefaction of PTCs. However, the mechanism of cellular 
enlargement of PT is not clear. In previous reports, a variety of factors, including insulin or tubular cell autophagy, 
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Figure 4. Phenotypes of PHD2 conditional knockout mice fed HFD or LFD. Body weight (A) serum 
concentrations of free fatty acids (B, FFA) in the four experimental groups. Phd2-cKO; tamoxifen (Tam)-
inducible PT-specific Phd2 knockout mice, Control; littermate control mice, LFD; low fat diet, HFD; high 
fat diet. (C) Urinary excretion of albumin (u-alb), neutrophil gelatinase-associated lipocalin (u-NGAL) and 
cystatin C in the four experimental groups. *p < 0.05 vs. Control LFD; #p < 0.05 vs. Control HFD, n = 8.  
(D) CD34 immunostaining to assess peritubular capillary density. Bar graph shows the number of CD34-
positive cells in a high power field (HPF). Scale bar is 50 μ m. *p < 0.05 vs. Control LFD; #p < 0.05 vs. Control 
HFD, n = 8. (E) Immunostaining for pimonidazole to detect hypoxic tissue. Bar graph shows the quantitation 
of pimonidazole-positive areas. Scale bar is 50 μ m. *p < 0.05 vs. Control LFD; #p < 0.05 vs. Control HFD, n = 8. 
(F) Representative findings of PTC in EM. In HFD mice, endothelial cells of PTC was enlarged, basement 
membrane was thickening (*), slit structures collapsed (black arrows), and lumen of PTC was narrowing, which 
were ameliorated in Phd2-cKO HFD mice. (G) Representative pathology of the kidneys, including glomeruli 
and tubulointerstitial lesions, from each experimental group. Bar graph shows the average areas of proximal 
tubule cells and glomeruli. *p < 0.05 vs. Control LFD; #p < 0.05 vs. Control HFD, n = 8.
www.nature.com/scientificreports/
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could also induce tubular cell enlargement. Insulin is a well-known inducer of cellular hypertrophy by activating 
mammalian-target of rapamycin (mTOR)/S6 kinase pathway26,27. It has been also reported that autophagy-deficient 
renal tubular cells in Atg6-deficient mice accumulated deformed mitochondria and cytoplasmic inclusions, lead-
ing to cellular hypertrophy28 and that, in obesity-induced renal damages, autophagy insufficiency in PT cells 
exacerbates proteinuria-induced tubulointerstitial lesions29,30. In our study, PT enlargement was alleviated in 
HFD-fed Phd2-cKO mice, supporting the idea that tubular hypertrophy in obesity-induced kidney injury may 
be caused by insufficient hypoxic response in PT. Cellular hypertrophy is often associated with cell growth 
arrest31,32 and hypoxia is known to be one environmental factor that halts the cell cycle and cell proliferation33,34. 
Hypoxia was reported to upregulate the cyclin dependent kinase inhibitors p21Cip1 and p27Kip1, which block 
cell cycle progression35. Hypoxia may also induce cell cycle arrest by inhibiting c-Myc transcriptional activity36. 
Another molecular mechanism for the relationship between hypoxic condition and cellular hypertrophy is the 
AMP-activated protein kinase (AMPK) signaling pathway that is activated by increased ratio cellular AMP/ATP 
ratio in hypoxic condition37. AMPK activation attenuated cellular hypertrophy38,39 by inhibiting protein synthesis 
through the mTOR pathway40. Using models for renal disease, Li et al. showed that HIF-1α and AMPK were 
linked at a molecular level during the response to hypoxic stress in the pathophysiology of CKD. AMPK acti-
vation was decreased in the subtotal nephrectomy model and was markedly restored by HIF-1α activation41. In 
our study, we speculate that HIF-1α did not function normally and AMPK may not have been fully restored by 
HIF-1α to facilitate cellular adaptation to hypoxia, resulting in cellular hypertrophy.
In the present study, we observed in detail PTC injuries in EM. Of note, in HFD mice, endothelial cells of PTC 
was enlarged, basement membrane was thickening, slit structures collapsed, and lumen of PTC was narrowing, 
which are new findings in obesity induced renal injuries and firstly reported. In addition to PTC rarefaction, 
these PTC injuries may contribute to hypoxic tissue insults in obese kidney. Although previous studies of obesity 
induced renal histological changes in human focused primarily on the glomerular area and obesity-related glo-
merulopathy has been characterized by glomerulomegaly with or without focal segmental glomerulosclerosis4, 
whether new findings in the present study are observed also in human needs to be evaluated in the future study.
One salient finding in our study is that albuminuria and glomerular hypertrophy in histology were also remit-
ted by improving the hypoxic condition through an intervention affecting PHD2. We speculate that the activation 
of HIF-VEGF pathway by PHD2 deletion in PT might lead to the restoration of post-glomerular PTC network, 
resulting in the reduction of glomerular afterload and the amelioration of glomerular hypertension and hypertro-
phy. These alterations cumulated in the reduction of albuminuria in obese mice. Alternatively, this result is related 
to a novel pathological link between tubular lesion and glomerular lesion in diabetic nephropathy we recently 
reported42. In this study, the decreased expression of NAD+ -dependent deacetylase Sirt1 in PT initiates diabetic 
albuminuria through the downregulation of Sirt1 and the upregulation of claudin-1, a tight junction component 
in podocytes. The present study provides evidence for this renal tubule–glomeruli communication and through 
this communication, the recovery from tubular damages leads to the recovery from glomerular damages and 
albuminuria. Therefore, the manipulation targeting PHD2-dependent hypoxic response has a promise for inhib-
iting the progression of glomerular damage in obese-induced kidney disease.
Several limitations of the present study merit comments. The present study demonstrated the results with 
short diet duration and there may be different findings with longer duration. In addition, it is difficult to show 
the activity of PHD2 in vivo and also to show the expression of HIF-1α by lacking of high quality antibodies. 
Instead, we have demonstrated that hypoxic state is detected by pimonidazole staining and shown the expression 
of mRNAs or proteins of downstream genes, but not HIF-1α . Although it has been described that the increase in 
glomerular basement membrane thickness may be seen after the onset of diabetes, we have firstly reported that 
basement membrane of tubules is already thickened in obesity before the onset of diabetes. However, it is needed 
to make sure of whether the same histological changes are observed in obesity in human. Further studies are 
required to clarify these limitations.
Figure 5. Effects of insulin and free fatty acids on the hypoxic response of HK-2 cells. The mRNA 
expression of SLC2A1 (Glut1: glucose transporter1) (A) and VEGFA (B). HK-2 cells were subjected to 
normoxic (normoxia) or hypoxic (hypoxia) culture conditions and pretreated with vehicle (groups 1 and 2), 
insulin (groups 3 and 4) or free fatty acids (FFA) (groups 5 and 6). Each bar graph represents the results of six 
experiments. *p < 0.05 vs. group 1, #p < 0.05 vs. group 3, n = 8.
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In conclusion, this is the first study to demonstrate that a hypoxic condition due to inadequate hypoxic 
response is a pathophysiological effect associated with obesity-induced renal injury. Normalization of hypoxic 
response by the downregulation of PHD2 in PT ameliorated hypoxic damage not only of PT lesions also in glo-
merular lesions. An early intervention targeting PHD2, specifically in the proximal area, may represent a novel 
therapeutic strategy against the progression of obesity-induced kidney injury.
Materials and Methods
Animal 1: HFD-fed wildtype mice. Eight-wk-old male C57BL/6J mice (Clea Japan, Tokyo, Japan) weigh-
ing 20 ± 1 g were housed in a temperature- and light (22 ± 1 °C; 12-hour light/dark cycle)-controlled room with 
ad libitum access to tap water and standard mouse chow. Animals were fed LFD, (10% lard, Research Diets Inc. 
New Brunswick, NJ; n = 8) or HFD (60% lard, Research Diets Inc.; n = 8) during the 12-wk experimental protocol 
as described before5.
Animal 2: Inducible PT-specific PHD2 knockout mice. We generated PT-specific conditional Phd2 
knockout (Phd2-cKO) mice by crossing the Phd2F/F mice from Dr. Yoji Andrew Minamishima (Keio University)16 
and the Ndrg1-CreERT2/+ mice with a PT-specific Ndrg1 gene promoter from Prof. Motoko Yanagita (Kyoto 
University)17. To obtain Phd2-cKO mice, Phd2F/F mice were crossed with Ndrg1-Cre mice to generate Phd2+/F; 
Ndrg1-Cre mice. Phd2+/F; Ndrg1-Cre mice were then crossed with Phd2+/F mice to generate Phd2F/F; Ndrg1-Cre 
(Phd2-cKO) mice and Phd2+/+; Ndrg1-Cre (Control) as littermate controls. Genomic DNA was isolated from tail 
biopsies at 4 week of age using a DNeasy kit (Qiagen Inc., Valencia, CA, USA) and genomic DNA samples were 
screened by polymerase chain reaction using the transgene-specific oligonucleotide primers shown in Table 2. 
The primers used to amplify the Phd2F/F allele are also shown in Table 2. The Cre gene was designed to be specif-
ically activated by the estrogen receptor (ER) agonist, tamoxifen (Tam). PT-specific conditional Phd2 knockout 
mice (Phd2-cKO) and their control littermates (Control) were maintained on LFD (n = 8) or HFD (n = 8) from 
8 to 20 wk of age. Mice were divided into 8 groups; (1) LFD-fed Control mice without Tam injection (sunflower 
oil vehicle injected) (Control LFD/Tam−); (2) LFD-fed Phd2-cKO mice without Tam injection (Phd2-cKO LFD/
Tam−); (3) LFD-fed Control mice with Tam injection (Control LFD/Tam+ ); (4) LFD-fed Phd2-cKO mice with 
Tam injection (Phd2-cKO LFD/Tam+ ); (5) HFD-fed Control mice without Tam injection (Control HFD/Tam−); 
(6) HFD-fed Phd2-cKO mice without Tam injection (Phd2-cKO HFD/Tam−); (7) HFD-fed Control mice with 
Tam injection (Control HFD/Tam+ ); and (8) HFD-fed Phd2-cKO mice with Tam injection (Phd2-cKO HFD/
Tam+ ). At 8 wk of age, mice received 1 mg of tamoxifen (Sigma Aldrich, St. Louis, MO, USA) by intraperitoneal 
injection for 5 consecutive days as described previously43. To visualize renal hypoxia, pimonidazole (60 mg/kg) 
was administered by intraperitoneal injection 90 min before sacrifice44. Mice were kept on HFD or LFD and sac-
rificed on week 12 as described in the Animal-1 experiment.
Blood and urine analyses. Serum concentrations of insulin and free fatty acids (FFA) were measured with 
LabAssay® (Wako Pure Chemical Industries, Ltd., Osaka, Japan). Urinary albumin was measured by Albuwell M 
(Exocell Inc., Philadelphia, PA, USA) and neutrophil-associated lipocalin (NGAL) and cystatin C were measured 
by ELISA kits (Quantikine, R&D Systems, MN, USA).
Morphological examination and Immunohistochemistry. Kidney sections (5 μ m) were stained 
with periodic acid-Schiff ’s stain45. Immunohistochemical staining was performed using primary antibodies 
against CD34 (ab81289), PHD2 (ab109088) and vascular endothelial growth factor (VEGF) (ab46154) (Abcam, 
Cambridge, MA, USA) and an anti-pimonidazole antibody (Hypoxyprobe™ -1 Omni Kit, Burlington, MA, USA). 
Horseradish peroxidase-conjugated anti-rabbit IgG antibodies (Dako, Glostrup, Denmark) were used as second-
ary antibodies. Staining was visualized with a diaminobenzidine (DAB) chromogen, followed by counterstain-
ing with hematoxylin. The extent of histochemical and immunohistochemical staining were quantified using 
computer-assisted image analysis46. Sections incubated with normal rabbit serum instead of the primary anti-
serum served as negative controls. Fifty glomeruli and fifty proximal tubular cells were counted in one kidney 
section from each mouse. The areas of the glomeruli and PT were measured by image analysis of high magnifica-
tion photographs. Immunostaining was assessed at 100x, 200x or 400x magnification using 20 randomly selected 
fields for each mouse. These morphological evaluations were conducted in a blinded manner by two independent 
observers.
Transmission electron microscopic (TEM) analysis. TEM analysis was performed as previously 
reported47. Briefly, the kidneys were dissected out without any perfusion and were fixed with 2.5% glutaraldehyde 










Table 2.  Sequences of primers for genotyping. Ndrg1; N-myc downstream regulated gene 1, Phd2; prolyl-
hydroxylase domain-containing protein 2.
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tetroxide, dehydrated through ethanol, acetone, QY1, and embedded into the epon. For 72 hours of complete 
polymerization with pure epon, ultrathin sections were prepared with a thickness of 70 nm and stained with ura-
nyl acetate and lead citrate for 10 minutes. The sections were observed under a transmission electron microscope 
(JEOL model 1400plus).
Cell culture. The human renal proximal tubular cell line, HK-2 cells (American Type Culture Collection, 
Rockville, MD, USA) were expanded in Dulbecco’s modified Eagle’s medium nutrient mixture F-12 (GIBCO Life 
Technologies, Foster City, CA, USA) with 10% bovine serum (FBS) supplemented with 50 U/mL penicillin and 
50 μg/mL streptomycin in a CO2 incubator (95% air and 5% CO2, 37 °C and 95% humidity; defined as normoxia).
Hypoxic exposure and stimulation by insulin or FFA. Early passage (passages 3–4) HK-2 cells were 
grown to 80% confluence and made quiescent by serum starvation for 24 h. Cells were then exposed to hypoxia 
(1% O2, 5% CO2, 94% nitrogen gas) for 24 h in a hypoxia workstation (Hirasawa Works, Tokyo, Japan) or 
remained in the CO2 incubator used for routine culture (normoxia). An oxygen sensor was used to ensure 
that the oxygen concentration inside the workstation was maintained at 1% throughout the experiments 
(MC-8G-S, Iijima electronics corporation, Aichi, Japan). Cells were further supplemented with 1 μ M human 
insulin (Sigma Aldrich) or 0.3 mM FFA. The FFA stock solution consisted of 6.35 mM sodium palmitate (Sigma 
Aldrich) and 12.7 mM sodium oleate (Sigma Aldrich) in FFA-free bovine serum albumin (BSA) (1.8 mM) 
as previously described48,49. Cells were divided into six groups: (1) cells without insulin or FFA in normoxia 
(normal O2 concentration of 20%), (2) cells without insulin or FFA in hypoxia, (3) cells with insulin in nor-
moxia, (4) cells with insulin in hypoxia, (5) cells with FFA in normoxia and (6) cells with FFA in hypoxia. After 
incubation for 24 h, cells were collected using TRIzol reagent (Invitrogen, Carlsbad, CA) to perform real-time 
RT-PCR.
Real-time RT-PCR. Equal amount (1 μ g) of total RNA from each sample was subjected to reverse transcrip-
tion in a 20 μ L reaction mixture containing random primers and Superscript II enzyme (Invitrogen). Real-time 
PCR was performed using an ABI Step One Plus sequence detector (Applied Biosystems, Foster City, CA)50. 
mRNA levels were normalized to those of RPLP0 (36B4) genes. The sequences of primers used are shown in 
Table 3.
Statistical Analysis. Data are expressed as means ± standard error of mean. One-way analysis of variance 
was used to determine significant differences among groups. In the overall analysis of variance, the Kruskal–
Wallis test for multiple comparisons was used to assess individual group differences. P < 0.05 was considered 
statistically significant.
Ethics Statement. This study was performed in accordance with the Institutional Guidelines on Animal 
Experimentation at Keio University. All methods were carried out in accordance with the guidelines for animal 
experiments of the Ministry of Education, Culture, Sports, Science and Technology, Japan. The experimental pro-
tocols were approved by the Animal Care and Experimentation Committee in Keio University (ID; 09119-(3)). 
All surgery was performed under sodium pentobarbital anesthesia by intraperitoneal injection, and all efforts 
were made to minimize suffering. At the end of the experiments, the mice were euthanized by intraperitoneal 

























Table 3.  Sequences of each primer for real-time RT-PCR. Vegfa; vascular endothelial growth factor A, 
SLC2A1; glucose transporter 1 (GLUT1), Pgk1; Phosphoglycerate kinase 1, Ldha; Lactate dehydrogenase A, 
Rplp0; 60S acidic ribosomal protein P0 (36B4).
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